Please use this identifier to cite or link to this item:
http://adhlui.com.ui.edu.ng/jspui/handle/123456789/1820
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Olorunsogo, O.O | - |
dc.contributor.author | Bbbabunmi, E. | - |
dc.date.accessioned | 2022-01-28T16:16:23Z | - |
dc.date.available | 2022-01-28T16:16:23Z | - |
dc.date.issued | 1992 | - |
dc.identifier.citation | Afri J Med Med Sci 1992, 21(1): 17-21 | en_US |
dc.identifier.issn | 1116-4077 | - |
dc.identifier.uri | http://adhlui.com.ui.edu.ng/jspui/handle/123456789/1820 | - |
dc.description.abstract | Nifedipine, a 1,4-dihydropyridine Ca2+ -channel blocker inliibits calmodulin-stimulated activity of erytlirocyte plasma membrane (Ca 2 + + Mg2 + ) -ATPase. Its inhibition of the basal activity of the enzyme increases on pre-incubation with membranes. The maximum velocity, affinity for ATP and Ca 2+ -sensitivity of pump are reduced by micromolar amounts of the antihypertensive drug. These results suggest that 1,4-dihydropyridines may interact with calcium-binding proteins and calcium-dependent enzymes at their calciumbinding sites. | en_US |
dc.description.sponsorship | College of Medicine, University of Ibadan, Nigeria. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Spectrum Books Limited | en_US |
dc.subject | Enzyme | en_US |
dc.subject | Erytlirocyte plasma membrane (Ca 2 + + Mg2 + ) -ATPase | en_US |
dc.subject | Nifedipine, a 1,4-dihydropyridine Ca2+ -channel blocker | en_US |
dc.title | Calmodulin antagonism and inhibition of erythrocyte plasma membrane Ca + -pump by nifedipine, a calcium channel blocker | en_US |
dc.type | Article | en_US |
Appears in Collections: | African Journal of Medicine and Medical Sciences |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Olorunsogo-Bababunmi_Calmodulin_1992.pdf | Article | 11.81 MB | Adobe PDF | View/Open |
Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.